期刊文献+

原发性胆汁性肝硬化血清学免疫功能分析

Immunological characteristics of primary biliary cirrhosis patients in serum.
下载PDF
导出
摘要 目的总结原发性胆汁性肝硬化(PBC)的血清学免疫功能特点。方法分析16例PBC患者一般资料、其他免疫性疾病史、临床表现、血清学免疫功能及肝组织病理。结果本组女性13例,男性3例,平均年龄(59.44±9.93)岁,血清学免疫功能检出情况:免疫球蛋白:IgM升高8例(8/16,50%),IgA升高7例(7/16,43.8%).IgG升高5例(5/16,31.3%)。非特异性抗体:抗核抗体(ANA)阳性率最高(12/16,75%),其中包括抗线粒体型(5/16,31.3%).Jo-1型(3/16.18.8%),抗SSA/SSB型(2/16,12.5%);双链DNA(DSDNA)阳性率12.5%(2/16)。特异性自身抗体:抗线粒体抗体M2亚型似(AMA-M2)阳性率较高(6/16,37.5%),其他阳性有抗肝/肾微粒体抗体(LKM1)(3/16,18.8%),抗核心蛋白抗体(GP210)(2/16.12.5%)。结论PBC患者血清学免疫功能明显异常。 Objective To summary the immunological characteristics of serum in primary biliary cirrhosis(PBC) patients. Methods Clinical data of 16 cases of PBC were reviewed, including general status, the history of other immune diseases, the clinical manifestation, immunological function in serum, and pathologic data of hepatic tissue. Result Among 16 patients, 13 were female, the mean age was (59.44+9.93) years old. The major symptoms in these patients were jaundice (81.3%) and pruritus (37.5%) . Immune function was abnor- mal: IgM in 8 cases (50%) , IgA in 7 cases (43.8%) , IgG in 5 cases (31.3%) . Non-specific antibody: positivity of antinucIear antibody (ANA) was 75%, among them, anti-mitoehondrlaI subtype was 31.3%, Jo- 1 subtype was 18.8%, SSA/SSB antibody subtype was 12.5%. 12.5% of them were double strands DNA (DS- DNA) . Anti-mitochondrial antibody M2 subtype (AMA-M2) was 37.5%, liver/kidney microsomal antibodyl (LKM1) was 18.8%, core protein antibody (GP210) was 12.5%. Conclusion Immune function of serum in primary biliary cirrhosis patients was abnormal obviously.
出处 《云南医药》 CAS 2006年第5期426-429,共4页 Medicine and Pharmacy of Yunnan
关键词 肝硬化 胆汁性 血清学 免疫功能 Liver cirrhosis, biliary Serology Immunological iunction
  • 相关文献

参考文献7

二级参考文献34

  • 1韩玉坤,张文瑾,陈菊梅,周华,王林杰.自身免疫性肝病临床与病理研究[J].中华肝脏病杂志,2001,9(S1):82-84. 被引量:11
  • 2Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet, 1996, 348:1399-1402.
  • 3Ermann J, Fathman CG. Autoimmune disease: genes, bugs and failed regulation. Nat Immunol, 2001, 2:759-761.
  • 4Long SA, Van de Water J, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobioties. Autoimmun Rev, 2002, 1:37-42.
  • 5Greshwin ME, Ansari AA, Mackay IR, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.Immunol Rev, 2000, 174:210-225.
  • 6Odin JA, Huebert RC, Casciola-Ro~en L, et al. Bcl-2-dependent oxidation of pyruvate dehygrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis, J Clin Invest, 2001, 108:223-232.
  • 7Parikh-Patel A, Gold EB, Worman H, et al. Risk factors for primary billary cirrhosis in a cohort of patients from the United States.Hepatology, 2001, 33 : 16-21.
  • 8Shlgematsu H, Shlmoda S, Nakarnura M, et al. Fine specificity of T cells reactive to human PDC-E2 163-172 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implication for molecular mimicry and cross-recognition among mitochondrial antoantigens. Hepatology, 2000, 32:901-909.
  • 9Neuberger J. Antibodies and primary biliary cirrhosis-piecing together the jigsaw. J Hepatol, 2002, 36:126-129.
  • 10Swain MG, Mafic M. Defective corticotropin-releasing hormone mediated neuroendocfine and behavioral responses in cholestatic liver rats: implications for cholestatic liver disease-related sickness behaviors. Hepatology, 1995, 22:1560-1564.

共引文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部